We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Botanix Pharmaceuticals is a biotechnology business based in Australia. Botanix Pharmaceuticals shares (BOT) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian dollars. Botanix Pharmaceuticals has a market cap (total outstanding shares value) of $76.9 million. If you're looking to buy shares, check out the steps below.
Our top pick for
US stocks
Our top pick for
Best Overall Broker
Our top pick for
Best low-cost broker
| 52-week range | $0.053 - $0.099 |
|---|---|
| 50-day moving average | $0.0758 |
| 200-day moving average | $0.0675 |
| Target price | N/A |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-0.011 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the last close of A$0.075
| 1 week (2022-05-12) | 15.38% |
|---|---|
| 1 month (2022-04-19) | -9.64% |
| 3 months (2022-02-18) | 29.31% |
| 6 months (2021-11-19) | 25.00% |
| 1 year (2021-05-19) | 2.74% |
|---|---|
| 2 years (2020-05-19) | 74.42% |
| 3 years (2019-05-17) | -34.78% |
| 5 years (2017-05-19) | 50.00% |
| Operating margin TTM | 5603232% |
|---|---|
| Gross profit TTM | $315,799 |
| Return on assets TTM | -29.9% |
| Return on equity TTM | -53.53% |
| Profit margin | 0% |
| Book value | 0.015 |
| Market capitalisation | $76.9 million |
TTM: trailing 12 months
We're not expecting Botanix Pharmaceuticals to pay a dividend over the next 12 months.
Botanix Pharmaceuticals's shares were split on a 1:3 basis on 15 June 2016. So if you had owned 3 shares the day before the split, the next day you would own 1 share. This wouldn't directly have changed the overall worth of your Botanix Pharmaceuticals shares – just the quantity. However, indirectly, the new 200% higher share price could have impacted the market appetite for Botanix Pharmaceuticals shares which in turn could have impacted Botanix Pharmaceuticals's share price.
Over the last 12 months, Botanix Pharmaceuticals's shares have ranged in value from as little as $0.053 up to $0.099. A popular way to gauge a stock's volatility is its "beta".
Beta measures a share's volatility in relation to the market. The market (AU average) beta is 1, while Botanix Pharmaceuticals's is 2.396. This would suggest that Botanix Pharmaceuticals's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Botanix Pharmaceuticals Limited, a clinical stage synthetic cannabinoid pharmaceutical company, engages in the research and development of dermatology and antimicrobial products in Australia. Its product pipeline include BTX 1503, a transdermal gel formulation for the treatment of serious acne in adults and teenagers that has completed Phase II clinical trials; BTX 1801, which has completed Phase IIa clinical trials for the treatment of staphylococcus aureus and methicillin resistant staphylococcus aureus; BTX 1702 that is in Phase Ib clinical trials for the treatment of papulopustular rosacea; and BTX 1204A for the treatment of atopic dermatitis. The company was incorporated in 1984 and is based in North Perth, Australia.
Everything we know about the OD6 Metals IPO, plus information on how to buy in.
Steps to owning and managing Winton Land shares.
Everything we know about the Summit Minerals IPO, plus information on how to buy in.
The picks and shovels approach is one way to gain exposure to the crypto market. Here is an ETF you could consider.
Everything we know about the Regener8 Resources IPO, plus information on how to buy in.
While crypto ETFs remain a relatively new concept, here is how you can invest in one of the first physically back Bitcoin ETFs.
Here is your how to guide on buying the first Ethereum backed ETF in Australia.
Everything we know about the Southern Palladium Limited IPO, plus information on how to buy in.
Everything we know about the Coolabah Metals IPO, plus information on how to buy in.
